Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

220
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
220
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

153
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
153
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

178
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Health-Head and Neck Cancers: Addressing Confounding Through Negative Control and Quantitative Bias Analyses.

Community dentistry and oral epidemiology·2025
Same author

Canada's First National Oral Health Research Strategy (2024-2030).

Journal of dental research·2024
Same author

A Cluster Analysis of Oral and Cognitive Health Indicators in the CLSA: An Exploratory Study on Cholinergic Activity as the Link.

JDR clinical and translational research·2023
Same author

Prenatal Substance Use Disorders and Dental Caries in Children.

Journal of dental research·2020
Same author

Functional Outcomes and Urological Complications after Genital Gender Affirming Surgery with Urethral Lengthening in Transgender Men.

The Journal of urology·2020
Same author

Quantitative Bias Analysis of misclassification in case-control studies: an example with Human Papillomavirus and Oropharyngeal Cancer.

Community dental health·2020
Same journal

School - based oral health promotion strategies: A global scoping review.

Community dental health·2026
Same journal

The primordial policy gap in dental caries control in Iran: From national DMFT success to the persistent challenge of the significant caries index (SIC): Policy brief.

Community dental health·2026
Same journal

Oral pain among young adolescents in Tanzania: A cross-sectional study.

Community dental health·2026
Same journal

Biosafety practices in Brazilian dentistry after the COVID-19 public health emergency: Persistence and discontinuation of protective measures.

Community dental health·2026
Same journal

Tobacco use and its impact on oral health among female adolescents in Riyadh, Saudi Arabia.

Community dental health·2026
Same journal

Associations between ethnicity, socioeconomic status and dental caries in children: A population-based record linkage longitudinal cohort study.

Community dental health·2026
See all related articles

Related Experiment Video

Updated: Jul 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Methodological Issues with Head and Neck Cancer Prognostic Risk Prediction Models.

H Ghanati1, S Madathil1, M Al-Tamimi1

  • 1Faculty of Dental Medicine and Oral Health Sciences, McGill University, Canada.

Community Dental Health
|September 18, 2023
PubMed
Summary
This summary is machine-generated.

Current head and neck cancer (HNC) risk models lack methodological detail. A review found high bias and limited clinical applicability, hindering accurate HNC prognosis.

Keywords:
Head and Neck NeoplasmsModelsPrognosisReviewRisk AssessmentStatistical

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.7K

Related Experiment Videos

Last Updated: Jul 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.7K

Area of Science:

  • Oncology
  • Biostatistics
  • Epidemiology

Background:

  • Prognostic risk prediction models are crucial for head and neck cancer (HNC) management.
  • Existing HNC risk models require comprehensive methodological evaluation.
  • This study aims to identify strengths and limitations in HNC risk prediction model development.

Approach:

  • A systematic scoping review was conducted.
  • Searches included major biomedical databases (Medline, Embase, Scopus, Web of Science, CAB Abstracts).
  • The PROBAST tool was used for critical appraisal of study quality.

Key Points:

  • Nine studies developing or validating HNC risk prediction models were included.
  • All reviewed models exhibited a high risk of bias, primarily in the analysis domain.
  • Only two studies raised significant concerns regarding clinical applicability.

Conclusions:

  • Published HNC risk prediction models offer insufficient methodological transparency.
  • Assessing the quality and clinical utility of current HNC models is challenging.
  • Future research must adhere to reporting guidelines for prediction modeling studies to improve reliability.